Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Share-based Compensation: 2010-2014

Historic Share-based Compensation for China Pharma Holdings (CPHI) over the last 2 years, with Mar 2014 value amounting to $128,024.

  • China Pharma Holdings' Share-based Compensation fell 43.47% to $128,024 in Q1 2014 from the same period last year, while for Mar 2014 it was $213,256, marking a year-over-year decrease of 49.86%. This contributed to the annual value of $78,270 for FY2022, which is 413.48% up from last year.
  • Per China Pharma Holdings' latest filing, its Share-based Compensation stood at $128,024 for Q1 2014, which was up 156.53% from -$226,490 recorded in Q2 2013.
  • China Pharma Holdings' 5-year Share-based Compensation high stood at $226,490 for Q1 2013, and its period low was -$226,490 during Q2 2013.
  • For the 3-year period, China Pharma Holdings' Share-based Compensation averaged around $53,949, with its median value being $85,232 (2012).
  • Over the last 5 years, China Pharma Holdings' Share-based Compensation had its largest YoY gain of 300.95% in 2013, and its largest YoY loss of 365.73% in 2013.
  • China Pharma Holdings' Share-based Compensation (Quarterly) stood at $63,829 in 2010, then declined by 10.53% to $57,109 in 2011, then surged by 112.72% to $85,232 in 2012, then slumped by 365.73% to -$226,490 in 2013, then crashed by 43.47% to $128,024 in 2014.
  • Its Share-based Compensation stands at $128,024 for Q1 2014, versus -$226,490 for Q2 2013 and $226,490 for Q1 2013.